Article
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma
16 Feb 2021
Abstract excerpt
CYP4B1 belongs to the mammalian CYP4 enzyme family and is predominantly expressed in the lungs of humans. It is responsible for the oxidative metabolism of a wide range of endogenous compounds and xenobiotics. In this study, using data from The Cancer Genome Atlas (TCGA) project and the Gene Expression Omnibus (GEO) database, a secondary analysis was performed to explore the expression profile of CYP4B1, as well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
